Biotechnology
The Biotechnology industry has a total of 604 stocks, with a combined market cap of $1.1 trillion and total revenue of $105.41 billion.
Market Cap
1.1T
Revenue
105.41B
Profits
-41.76B
PE Ratio
n/a
Profit Margin
-39.62%
Dividend Yield
0.04%
604 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 118.84B | 4.36% | 2,075,508 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 79.67B | 1.74% | 930,982 | 14.25B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 53.69B | 2.15% | 1,612,885 | 3.21B |
| 4 | ARGX | argenx SE | 49.07B | 0.36% | 540,917 | 3.68B |
| 5 | INSM | Insmed Incorporated | 37.34B | -0.07% | 1,850,092 | 447.02M |
| 6 | ONC | BeOne Medicines AG | 35.43B | -0.03% | 278,460 | 4.97B |
| 7 | BNTX | BioNTech SE | 23.59B | 1.28% | 838,274 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 23.46B | 2.52% | 5,386,587 | 2.35B |
| 9 | INCY | Incyte Corporation | 20.94B | 4.78% | 3,848,846 | 4.81B |
| 10 | GMAB | Genmab A/S | 20.39B | 4.09% | 1,727,672 | 3.85B |
| 11 | RVMD | Revolution Medicines, Inc. | 15.44B | 1.94% | 2,169,647 | - |
| 12 | ROIV | Roivant Sciences Ltd. | 15.03B | 1.46% | 6,104,459 | 20.33M |
| 13 | SMMT | Summit Therapeutics Inc. | 14.39B | 7.00% | 4,115,753 | - |
| 14 | BBIO | BridgeBio Pharma, Inc. | 14.26B | 0.78% | 3,334,251 | 353.78M |
| 15 | MRNA | Moderna, Inc. | 13.93B | 10.85% | 20,688,550 | 2.23B |
| 16 | IONS | Ionis Pharmaceuticals, Inc. | 13.20B | 3.77% | 2,651,310 | 966.96M |
| 17 | ASND | Ascendis Pharma A/S | 12.85B | -1.81% | 482,395 | 758.59M |
| 18 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.67B | -5.16% | 728,455 | 740.64M |
| 19 | EXEL | Exelixis, Inc. | 11.76B | 3.02% | 2,168,744 | 2.29B |
| 20 | BMRN | BioMarin Pharmaceutical Inc. | 11.54B | 2.04% | 2,019,267 | 3.09B |
| 21 | RNA | Avidity Biosciences, Inc. | 10.89B | 0.25% | 2,761,076 | 20.87M |
| 22 | TECH | Bio-Techne Corporation | 10.17B | 3.57% | 2,086,169 | 1.22B |
| 23 | JAZZ | Jazz Pharmaceuticals plc | 10.15B | -4.24% | 2,641,441 | 4.16B |
| 24 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.62B | 10.85% | 8,138,695 | 829.45M |
| 25 | ABVX | ABIVAX Société Anonyme | 9.41B | -3.35% | 1,803,858 | 6.23M |
| 26 | AXSM | Axsome Therapeutics, Inc. | 8.66B | 0.23% | 791,620 | 561.26M |
| 27 | HALO | Halozyme Therapeutics, Inc. | 8.60B | 2.71% | 3,809,407 | 1.24B |
| 28 | CAI | Caris Life Sciences, Inc. | 8.01B | 7.46% | 2,829,480 | 649.06M |
| 29 | CYTK | Cytokinetics, Incorporated | 7.90B | 5.45% | 2,440,608 | 87.21M |
| 30 | NUVL | Nuvalent, Inc. | 7.54B | -0.84% | 940,647 | - |
| 31 | KRYS | Krystal Biotech, Inc. | 7.23B | 1.91% | 392,453 | 373.16M |
| 32 | CDTX | Cidara Therapeutics, Inc. | 6.97B | 0.03% | 2,650,314 | 302.00K |
| 33 | PRAX | Praxis Precision Medicines, Inc. | 6.82B | -1.45% | 302,589 | 7.46M |
| 34 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.63B | -2.40% | 748,183 | 174.33M |
| 35 | PTCT | PTC Therapeutics, Inc. | 6.16B | -0.08% | 2,116,892 | 1.78B |
| 36 | BLTE | Belite Bio, Inc | 6.01B | 0.48% | 229,317 | - |
| 37 | KYMR | Kymera Therapeutics, Inc. | 5.88B | 1.45% | 1,000,593 | 43.74M |
| 38 | PCVX | Vaxcyte, Inc. | 5.87B | -2.56% | 1,317,812 | - |
| 39 | CRSP | CRISPR Therapeutics AG | 5.55B | 5.51% | 2,860,427 | 38.34M |
| 40 | COGT | Cogent Biosciences, Inc. | 5.29B | 1.52% | 2,696,775 | - |
| 41 | APGE | Apogee Therapeutics, Inc. | 5.28B | 0.95% | 1,701,716 | - |
| 42 | IMVT | Immunovant, Inc. | 5.25B | 3.72% | 2,853,146 | - |
| 43 | PTGX | Protagonist Therapeutics, Inc. | 5.14B | -2.27% | 730,365 | 209.22M |
| 44 | CELC | Celcuity Inc. | 4.86B | 1.18% | 546,552 | - |
| 45 | ACAD | ACADIA Pharmaceuticals Inc. | 4.56B | 3.02% | 1,366,440 | 1.05B |
| 46 | FOLD | Amicus Therapeutics, Inc. | 4.42B | 0.21% | 13,300,633 | 598.70M |
| 47 | GPCR | Structure Therapeutics Inc. | 4.37B | 0.75% | 1,218,605 | - |
| 48 | ADMA | ADMA Biologics, Inc. | 4.36B | 1.72% | 2,387,733 | 488.56M |
| 49 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.36B | -4.63% | 3,631,153 | 1.54M |
| 50 | TGTX | TG Therapeutics, Inc. | 4.30B | -1.64% | 2,854,414 | 531.90M |
| 51 | SRRK | Scholar Rock Holding Corporation | 4.21B | -3.39% | 755,444 | - |
| 52 | TERN | Terns Pharmaceuticals, Inc. | 4.17B | -2.22% | 2,278,361 | - |
| 53 | MIRM | Mirum Pharmaceuticals, Inc. | 3.95B | 1.19% | 838,874 | 471.79M |
| 54 | LEGN | Legend Biotech Corporation | 3.87B | 3.30% | 2,106,055 | 909.05M |
| 55 | LGND | Ligand Pharmaceuticals Incorporated | 3.86B | 2.09% | 144,492 | 251.23M |
| 56 | NAMS | NewAmsterdam Pharma Company N.V. | 3.86B | 1.61% | 782,067 | 35.24M |
| 57 | CORT | Corcept Therapeutics Incorporated | 3.76B | 2.37% | 3,823,768 | 741.17M |
| 58 | VKTX | Viking Therapeutics, Inc. | 3.65B | 0.50% | 3,675,590 | - |
| 59 | ACLX | Arcellx, Inc. | 3.59B | 0.29% | 823,544 | 35.90M |
| 60 | ARQT | Arcutis Biotherapeutics, Inc. | 3.58B | -3.25% | 1,350,534 | 317.93M |
| 61 | TARS | Tarsus Pharmaceuticals, Inc. | 3.39B | 0.18% | 409,015 | 366.10M |
| 62 | CNTA | Centessa Pharmaceuticals plc | 3.31B | -1.56% | 1,443,614 | 15.00M |
| 63 | VERA | Vera Therapeutics, Inc. | 3.30B | -1.17% | 1,541,152 | - |
| 64 | CGON | CG Oncology, Inc. | 3.26B | 0.82% | 691,424 | 2.17M |
| 65 | TVTX | Travere Therapeutics, Inc. | 3.20B | -6.06% | 2,765,432 | 435.83M |
| 66 | IDYA | IDEAYA Biosciences, Inc. | 3.17B | 3.63% | 1,502,020 | 214.83M |
| 67 | XENE | Xenon Pharmaceuticals Inc. | 3.17B | -1.89% | 1,485,011 | 7.50M |
| 68 | APLS | Apellis Pharmaceuticals, Inc. | 3.03B | -3.74% | 1,882,490 | 1.02B |
| 69 | DYN | Dyne Therapeutics, Inc. | 2.98B | -0.60% | 2,541,308 | - |
| 70 | VRDN | Viridian Therapeutics, Inc. | 2.93B | 1.72% | 2,171,486 | 70.79M |
| 71 | IRON | Disc Medicine, Inc. | 2.92B | -1.62% | 604,196 | - |
| 72 | NUVB | Nuvation Bio Inc. | 2.91B | -1.16% | 4,005,501 | 26.75M |
| 73 | MLYS | Mineralys Therapeutics, Inc. | 2.83B | 0.14% | 1,085,999 | - |
| 74 | BEAM | Beam Therapeutics Inc. | 2.80B | 5.59% | 2,076,932 | 55.70M |
| 75 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.78B | -0.96% | 1,340,758 | 578.20M |
| 76 | WVE | Wave Life Sciences Ltd. | 2.77B | 1.00% | 14,977,731 | 109.23M |
| 77 | DNLI | Denali Therapeutics Inc. | 2.69B | 7.43% | 2,774,893 | - |
| 78 | RCUS | Arcus Biosciences, Inc. | 2.68B | -0.37% | 1,545,053 | 240.00M |
| 79 | LQDA | Liquidia Corporation | 2.67B | -4.45% | 1,914,419 | 69.22M |
| 80 | TLX | Telix Pharmaceuticals Limited | 2.50B | -1.58% | 173,475 | 664.23M |
| 81 | SLNO | Soleno Therapeutics, Inc. | 2.48B | 2.03% | 1,461,587 | 98.68M |
| 82 | ADPT | Adaptive Biotechnologies Corporation | 2.46B | -0.37% | 3,352,049 | 252.75M |
| 83 | AAPG | Ascentage Pharma Group International | 2.43B | -3.49% | 4,796 | 54.52M |
| 84 | EWTX | Edgewise Therapeutics, Inc. | 2.43B | -2.67% | 1,044,314 | - |
| 85 | OCUL | Ocular Therapeutix, Inc. | 2.40B | -2.60% | 3,492,309 | 55.78M |
| 86 | RXRX | Recursion Pharmaceuticals, Inc. | 2.37B | 4.12% | 23,008,049 | 43.69M |
| 87 | MESO | Mesoblast Limited | 2.37B | 1.53% | 124,822 | 17.20M |
| 88 | SYRE | Spyre Therapeutics, Inc. | 2.35B | 1.23% | 751,394 | - |
| 89 | SRPT | Sarepta Therapeutics, Inc. | 2.34B | 6.07% | 3,768,134 | 2.41B |
| 90 | IMNM | Immunome, Inc. | 2.18B | 0.20% | 1,972,758 | 9.68M |
| 91 | RARE | Ultragenyx Pharmaceutical Inc. | 2.17B | -2.47% | 3,744,407 | 630.60M |
| 92 | HRMY | Harmony Biosciences Holdings, Inc. | 2.12B | - | 487,058 | 825.94M |
| 93 | IBRX | ImmunityBio, Inc. | 2.11B | 2.88% | 8,837,200 | 82.56M |
| 94 | GLPG | Galapagos NV | 2.11B | -0.76% | 155,080 | 336.64M |
| 95 | AUPH | Aurinia Pharmaceuticals Inc. | 2.04B | 0.92% | 1,091,739 | 265.81M |
| 96 | ZLAB | Zai Lab Limited | 2.02B | 0.61% | 712,524 | 441.63M |
| 97 | STOK | Stoke Therapeutics, Inc. | 2.01B | 8.20% | 1,130,685 | 205.63M |
| 98 | VCEL | Vericel Corporation | 1.99B | 6.09% | 674,750 | 258.72M |
| 99 | OLMA | Olema Pharmaceuticals, Inc. | 1.97B | -0.24% | 1,164,982 | - |
| 100 | MAZE | Maze Therapeutics, Inc. | 1.85B | -0.67% | 241,160 | 2.50M |
| 101 | ZYME | Zymeworks Inc. | 1.81B | -5.10% | 1,744,552 | 134.48M |
| 102 | SNDX | Syndax Pharmaceuticals, Inc. | 1.77B | 0.59% | 1,426,515 | 111.30M |
| 103 | NRIX | Nurix Therapeutics, Inc. | 1.77B | -0.34% | 1,686,049 | 83.69M |
| 104 | CLDX | Celldex Therapeutics, Inc. | 1.75B | 2.66% | 815,007 | 2.60M |
| 105 | MNKD | MannKind Corporation | 1.73B | - | 2,983,484 | 313.79M |
| 106 | ALMS | Alumis Inc. | 1.69B | 95.31% | 65,002,527 | 22.12M |
| 107 | SION | Sionna Therapeutics, Inc. | 1.66B | -8.89% | 266,423 | - |
| 108 | IMCR | Immunocore Holdings plc | 1.66B | 0.03% | 510,980 | 379.59M |
| 109 | FTRE | Fortrea Holdings Inc. | 1.62B | 5.54% | 2,830,754 | 2.76B |
| 110 | PGEN | Precigen, Inc. | 1.61B | 8.85% | 3,922,212 | 6.31M |
| 111 | AGIO | Agios Pharmaceuticals, Inc. | 1.60B | 0.07% | 927,602 | 44.79M |
| 112 | PHVS | Pharvaris N.V. | 1.56B | -3.34% | 147,910 | - |
| 113 | DNTH | Dianthus Therapeutics, Inc. | 1.55B | -1.87% | 718,413 | 3.08M |
| 114 | KOD | Kodiak Sciences Inc. | 1.53B | 0.20% | 816,245 | - |
| 115 | ATAI | AtaiBeckley Inc. | 1.45B | 3.36% | 3,105,515 | 3.02M |
| 116 | INVA | Innoviva, Inc. | 1.44B | -3.59% | 742,136 | 388.52M |
| 117 | TSHA | Taysha Gene Therapies, Inc. | 1.44B | 7.57% | 3,771,229 | 6.31M |
| 118 | RLAY | Relay Therapeutics, Inc. | 1.42B | 3.94% | 2,074,591 | 8.36M |
| 119 | TYRA | Tyra Biosciences, Inc. | 1.41B | 0.49% | 482,517 | - |
| 120 | TRVI | Trevi Therapeutics, Inc. | 1.41B | -3.35% | 2,044,770 | - |
| 121 | UPB | Upstream Bio, Inc. | 1.40B | -1.00% | 452,806 | 2.80M |
| 122 | EYPT | EyePoint, Inc. | 1.40B | -3.27% | 733,040 | 42.34M |
| 123 | QURE | uniQure N.V. | 1.39B | -1.41% | 1,296,694 | 15.75M |
| 124 | CAPR | Capricor Therapeutics, Inc. | 1.35B | 5.32% | 1,189,424 | 11.13M |
| 125 | ARDX | Ardelyx, Inc. | 1.35B | -8.70% | 5,045,159 | 398.23M |
| 126 | SVRA | Savara Inc. | 1.34B | -4.48% | 2,072,156 | - |
| 127 | MNMD | Mind Medicine (MindMed) Inc. | 1.33B | -0.52% | 2,404,984 | - |
| 128 | RAPP | Rapport Therapeutics, Inc. | 1.32B | 0.51% | 275,295 | - |
| 129 | TNGX | Tango Therapeutics, Inc. | 1.30B | 8.53% | 1,775,346 | 66.50M |
| 130 | MBX | MBX Biosciences, Inc. | 1.29B | -2.08% | 490,788 | - |
| 131 | ORKA | Oruka Therapeutics, Inc. | 1.29B | -0.97% | 459,418 | - |
| 132 | IMTX | Immatics N.V. | 1.28B | -1.95% | 286,155 | 99.45M |
| 133 | BHVN | Biohaven Ltd. | 1.28B | -3.12% | 3,183,863 | - |
| 134 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.25B | -0.09% | 2,082,699 | -665.00K |
| 135 | ANAB | AnaptysBio, Inc. | 1.22B | 1.64% | 466,030 | 169.47M |
| 136 | NVAX | Novavax, Inc. | 1.21B | 2.62% | 4,252,401 | 1.06B |
| 137 | OCS | Oculis Holding AG | 1.21B | 5.82% | 294,729 | 992.00K |
| 138 | ABCL | AbCellera Biologics Inc. | 1.17B | 13.70% | 6,155,543 | 35.33M |
| 139 | PHAT | Phathom Pharmaceuticals, Inc. | 1.16B | 3.41% | 377,194 | 147.19M |
| 140 | SANA | Sana Biotechnology, Inc. | 1.16B | 7.39% | 3,332,748 | - |
| 141 | XERS | Xeris Biopharma Holdings, Inc. | 1.15B | -1.83% | 2,295,733 | 266.14M |
| 142 | PHAR | Pharming Group N.V. | 1.14B | 0.89% | 25,667 | 362.27M |
| 143 | SEPN | Septerna, Inc. | 1.14B | -5.00% | 316,124 | 22.05M |
| 144 | NTLA | Intellia Therapeutics, Inc. | 1.13B | 3.84% | 4,300,566 | 57.53M |
| 145 | INBX | Inhibrx Biosciences, Inc. | 1.11B | -1.13% | 202,376 | 1.40M |
| 146 | SPRY | ARS Pharmaceuticals, Inc. | 1.10B | 1.64% | 1,777,379 | 142.77M |
| 147 | PVLA | Palvella Therapeutics, Inc. | 1.07B | 2.25% | 274,406 | - |
| 148 | GLUE | Monte Rosa Therapeutics, Inc. | 1.04B | 11.18% | 1,650,565 | 181.54M |
| 149 | CVAC | CureVac N.V. | 1.04B | -0.86% | - | 83.00M |
| 150 | ERAS | Erasca, Inc. | 1.03B | 4.01% | 4,536,032 | - |
| 151 | URGN | UroGen Pharma Ltd. | 1.02B | -1.08% | 488,179 | 96.52M |
| 152 | IOVA | Iovance Biotherapeutics, Inc. | 1.01B | 4.08% | 8,867,938 | 250.43M |
| 153 | XNCR | Xencor, Inc. | 1.00B | -1.47% | 1,109,690 | 150.13M |
| 154 | MRVI | Maravai LifeSciences Holdings, Inc. | 992.14M | 2.37% | 1,859,982 | 192.44M |
| 155 | NBTX | Nanobiotix S.A. | 971.63M | -2.49% | 75,929 | 11.93M |
| 156 | OMER | Omeros Corporation | 959.28M | -12.14% | 5,296,755 | - |
| 157 | MDXG | MiMedx Group, Inc. | 947.85M | 1.11% | 896,871 | 393.44M |
| 158 | NBY | NovaBay Pharmaceuticals, Inc. | 931.22M | 9.48% | 657,296 | 10.30M |
| 159 | TBPH | Theravance Biopharma, Inc. | 927.31M | -0.65% | 498,910 | 80.33M |
| 160 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 927.07M | 2.20% | 174,256 | - |
| 161 | ABUS | Arbutus Biopharma Corporation | 921.23M | 1.70% | 1,165,873 | 14.61M |
| 162 | ELVN | Enliven Therapeutics, Inc. | 898.52M | -0.46% | 505,445 | - |
| 163 | CRMD | CorMedix Inc. | 887.16M | -7.63% | 4,108,655 | 214.30M |
| 164 | DAWN | Day One Biopharmaceuticals, Inc. | 887.12M | 1.05% | 1,846,017 | 133.67M |
| 165 | BCAX | Bicara Therapeutics Inc. | 886.92M | 0.50% | 629,265 | - |
| 166 | GHRS | GH Research PLC | 875.86M | -8.67% | 856,511 | - |
| 167 | IVA | Inventiva S.A. | 875.33M | -1.30% | 223,061 | 19.93M |
| 168 | NKTR | Nektar Therapeutics | 874.08M | -3.37% | 474,038 | 62.60M |
| 169 | CMPX | Compass Therapeutics, Inc. | 873.30M | -1.60% | 2,404,371 | 850.00K |
| 170 | RAPT | RAPT Therapeutics, Inc. | 854.05M | 3.35% | 288,242 | - |
| 171 | VALN | Valneva SE | 846.13M | 10.17% | 29,489 | 211.09M |
| 172 | GERN | Geron Corporation | 842.63M | - | 5,448,045 | 183.40M |
| 173 | KURA | Kura Oncology, Inc. | 830.15M | - | 1,491,432 | 104.03M |
| 174 | VIR | Vir Biotechnology, Inc. | 829.19M | 2.94% | 2,370,407 | 16.86M |
| 175 | YDES | YD Bio Limited | 819.93M | -8.04% | 327,973 | 510.36K |
| 176 | ZBIO | Zenas BioPharma, Inc. | 815.92M | -8.49% | 3,123,491 | 15.00M |
| 177 | JANX | Janux Therapeutics, Inc. | 808.39M | -2.25% | 1,617,981 | 10.00M |
| 178 | MLTX | MoonLake Immunotherapeutics | 797.24M | -0.18% | 1,613,863 | - |
| 179 | KALV | KalVista Pharmaceuticals, Inc. | 796.10M | 0.57% | 1,177,046 | 1.43M |
| 180 | ORIC | ORIC Pharmaceuticals, Inc. | 792.75M | -0.12% | 1,667,175 | - |
| 181 | RIGL | Rigel Pharmaceuticals, Inc. | 785.59M | 5.07% | 422,918 | 282.08M |
| 182 | AVBP | ArriVent BioPharma, Inc. | 781.46M | -3.07% | 701,670 | - |
| 183 | ANNX | Annexon, Inc. | 760.18M | -2.30% | 3,200,544 | - |
| 184 | ARVN | Arvinas, Inc. | 759.77M | 5.91% | 837,564 | 312.30M |
| 185 | MPLT | MapLight Therapeutics, Inc. | 742.34M | -1.22% | 301,594 | - |
| 186 | ATXS | Astria Therapeutics, Inc. | 738.11M | 0.86% | 534,045 | 706.00K |
| 187 | RGNX | REGENXBIO Inc. | 717.84M | 5.82% | 568,292 | 161.32M |
| 188 | VTYX | Ventyx Biosciences, Inc. | 717.15M | 28.52% | 7,479,713 | - |
| 189 | DBVT | DBV Technologies S.A. | 704.68M | -2.12% | 575,683 | 5.50M |
| 190 | CTMX | CytomX Therapeutics, Inc. | 701.46M | 0.49% | 1,509,686 | 113.63M |
| 191 | LXEO | Lexeo Therapeutics, Inc. | 694.11M | 0.74% | 879,000 | - |
| 192 | PROK | ProKidney Corp. | 676.88M | 5.14% | 913,758 | 744.00K |
| 193 | REPL | Replimune Group, Inc. | 662.85M | 0.36% | 949,220 | - |
| 194 | IVVD | Invivyd, Inc. | 659.55M | -6.67% | 2,819,051 | 50.04M |
| 195 | FULC | Fulcrum Therapeutics, Inc. | 659.04M | -7.84% | 818,382 | 80.00M |
| 196 | PRME | Prime Medicine, Inc. | 655.04M | 3.64% | 4,264,355 | 5.98M |
| 197 | GYRE | Gyre Therapeutics, Inc. | 633.51M | -11.99% | 195,863 | 107.27M |
| 198 | JBIO | Jade Biosciences, Inc. | 605.88M | 0.38% | 315,022 | - |
| 199 | MGTX | MeiraGTx Holdings plc | 604.49M | -0.53% | 426,773 | 27.42M |
| 200 | CGEM | Cullinan Therapeutics, Inc. | 600.21M | 1.70% | 621,953 | - |
| 201 | GOSS | Gossamer Bio, Inc. | 592.53M | -6.57% | 5,590,350 | 44.05M |
| 202 | DRUG | Bright Minds Biosciences Inc. | 588.78M | 16.50% | 1,121,371 | - |
| 203 | ABSI | Absci Corporation | 586.45M | 4.28% | 2,884,791 | 2.82M |
| 204 | SLS | SELLAS Life Sciences Group, Inc. | 584.01M | -18.00% | 26,760,468 | - |
| 205 | ENGN | enGene Holdings Inc. | 553.29M | -5.38% | 200,750 | - |
| 206 | LYEL | Lyell Immunopharma, Inc. | 546.61M | -8.14% | 108,962 | 41.00K |
| 207 | KROS | Keros Therapeutics, Inc. | 541.99M | -0.73% | 467,345 | 246.72M |
| 208 | NAGE | Niagen Bioscience, Inc. | 541.40M | 4.81% | 1,335,108 | 124.71M |
| 209 | TENX | Tenax Therapeutics, Inc. | 538.37M | 7.71% | 441,547 | - |
| 210 | AUTL | Autolus Therapeutics plc | 532.29M | 7.53% | 2,564,625 | 51.13M |
| 211 | VSTM | Verastem, Inc. | 531.01M | 0.15% | 1,186,635 | 13.38M |
| 212 | LENZ | LENZ Therapeutics, Inc. | 527.24M | 2.25% | 419,857 | 17.50M |
| 213 | VTVT | vTv Therapeutics Inc. | 523.03M | -0.54% | 30,483 | 17.00K |
| 214 | DNA | Ginkgo Bioworks Holdings, Inc. | 521.19M | 3.38% | 1,314,904 | 180.61M |
| 215 | EVMN | Evommune, Inc. | 506.91M | 4.62% | 403,992 | 13.00M |
| 216 | LBRX | LB Pharmaceuticals Inc | 503.20M | -3.26% | 224,947 | - |
| 217 | DSGN | Design Therapeutics, Inc. | 502.42M | 1.50% | 197,111 | - |
| 218 | CRVS | Corvus Pharmaceuticals, Inc. | 498.87M | -1.62% | 2,235,297 | - |
| 219 | DRTS | Alpha Tau Medical Ltd. | 497.94M | 11.88% | 347,853 | - |
| 220 | ASMB | Assembly Biosciences, Inc. | 483.69M | -5.35% | 93,005 | 37.19M |
| 221 | PRTA | Prothena Corporation plc | 482.85M | -1.43% | 636,414 | 11.79M |
| 222 | OCGN | Ocugen, Inc. | 480.97M | 6.21% | 5,999,875 | 5.37M |
| 223 | VNDA | Vanda Pharmaceuticals Inc. | 480.46M | 3.30% | 2,102,251 | 212.07M |
| 224 | PEPG | PepGen Inc. | 470.24M | 2.55% | 492,769 | - |
| 225 | ANRO | Alto Neuroscience, Inc. | 468.48M | -8.77% | 418,895 | - |
| 226 | ZVRA | Zevra Therapeutics, Inc. | 467.83M | -0.36% | 801,594 | 84.39M |
| 227 | BCYC | Bicycle Therapeutics plc | 455.75M | -0.61% | 258,330 | 28.34M |
| 228 | KYTX | Kyverna Therapeutics, Inc. | 453.61M | -2.34% | 1,283,928 | - |
| 229 | VOR | Vor Biopharma Inc. | 451.86M | 10.30% | 1,404,930 | - |
| 230 | NBP | NovaBridge Biosciences | 447.33M | -11.21% | 3,106,197 | - |
| 231 | DMAC | DiaMedica Therapeutics Inc. | 443.70M | -0.23% | 472,920 | - |
| 232 | ADCT | ADC Therapeutics SA | 438.52M | -0.56% | 420,371 | 75.21M |
| 233 | IMRX | Immuneering Corporation | 433.91M | 1.66% | 1,647,854 | - |
| 234 | ALT | Altimmune, Inc. | 432.25M | -3.18% | 5,616,851 | 20.00K |
| 235 | SLDB | Solid Biosciences Inc. | 427.73M | 3.00% | 1,126,571 | - |
| 236 | IMMP | Immutep Limited | 421.69M | 1.38% | 99,039 | 3.31M |
| 237 | FBRX | Forte Biosciences, Inc. | 418.33M | 3.99% | 133,634 | - |
| 238 | LXRX | Lexicon Pharmaceuticals, Inc. | 414.27M | - | 1,166,197 | 70.86M |
| 239 | LCTX | Lineage Cell Therapeutics, Inc. | 411.96M | 0.59% | 1,274,312 | 10.82M |
| 240 | FDMT | 4D Molecular Therapeutics, Inc. | 410.80M | -1.51% | 529,143 | 120.00K |
| 241 | PRTC | PureTech Health plc | 409.77M | 0.92% | 865 | 6.39M |
| 242 | MNPR | Monopar Therapeutics Inc. | 408.07M | -1.08% | 401,743 | - |
| 243 | BNTC | Benitec Biopharma Inc. | 406.69M | 1.01% | 185,399 | - |
| 244 | EPRX | Eupraxia Pharmaceuticals Inc. | 393.62M | -3.12% | 41,546 | - |
| 245 | ENTA | Enanta Pharmaceuticals, Inc. | 391.95M | -2.37% | 212,083 | 65.32M |
| 246 | TECX | Tectonic Therapeutic, Inc. | 385.18M | 4.41% | 214,067 | - |
| 247 | RCKT | Rocket Pharmaceuticals, Inc. | 383.11M | -0.28% | 1,772,741 | - |
| 248 | HELP | Cybin Inc. | 371.28M | -3.75% | 724,308 | - |
| 249 | TRDA | Entrada Therapeutics, Inc. | 361.48M | -4.00% | 238,152 | 61.52M |
| 250 | AVXL | Anavex Life Sciences Corp. | 358.29M | 1.52% | 2,704,568 | - |
| 251 | XFOR | X4 Pharmaceuticals, Inc. | 347.12M | 3.39% | 243,843 | 33.98M |
| 252 | ACIU | AC Immune SA | 339.37M | -2.56% | 970,628 | 5.48M |
| 253 | AURA | Aura Biosciences, Inc. | 327.68M | -0.39% | 233,974 | - |
| 254 | XOMA | XOMA Royalty Corporation | 327.53M | -0.64% | 732,646 | 47.11M |
| 255 | CLLS | Cellectis S.A. | 322.10M | -3.08% | 62,473 | 82.55M |
| 256 | ALLO | Allogene Therapeutics, Inc. | 316.87M | 4.44% | 5,207,151 | 22.00K |
| 257 | ZURA | Zura Bio Limited | 314.06M | 0.63% | 740,730 | - |
| 258 | CAMP | Camp4 Therapeutics Corporation | 310.77M | - | 67,183 | 3.80M |
| 259 | NMRA | Neumora Therapeutics, Inc. | 309.29M | 11.31% | 5,335,525 | - |
| 260 | CADL | Candel Therapeutics, Inc. | 306.33M | 5.28% | 575,779 | - |
| 261 | RLMD | Relmada Therapeutics, Inc. | 299.20M | -3.55% | 380,416 | - |
| 262 | PBYI | Puma Biotechnology, Inc. | 295.29M | -1.35% | 375,681 | 212.00M |
| 263 | AARD | Aardvark Therapeutics, Inc. | 289.58M | 0.15% | 122,116 | - |
| 264 | LRMR | Larimar Therapeutics, Inc. | 288.44M | 0.30% | 870,889 | - |
| 265 | AVTX | Avalo Therapeutics, Inc. | 288.42M | -0.78% | 150,437 | 192.00K |
| 266 | ACRS | Aclaris Therapeutics, Inc. | 287.11M | - | 2,462,280 | 15.74M |
| 267 | PALI | Palisade Bio, Inc. | 286.09M | -8.57% | 3,823,762 | - |
| 268 | GLSI | Greenwich LifeSciences, Inc. | 284.43M | -3.21% | 232,634 | - |
| 269 | NGNE | Neurogene Inc. | 283.46M | -0.71% | 357,517 | 925.00K |
| 270 | MENS | Jyong Biotech Ltd. | 281.45M | 4.57% | 331,545 | - |
| 271 | ABEO | Abeona Therapeutics Inc. | 279.63M | -1.15% | 1,170,067 | 400.00K |
| 272 | FHTX | Foghorn Therapeutics Inc. | 278.80M | -1.00% | 195,350 | 24.52M |
| 273 | CTNM | Contineum Therapeutics, Inc. | 276.94M | -5.10% | 275,942 | - |
| 274 | TARA | Protara Therapeutics, Inc. | 274.37M | -5.01% | 1,292,109 | - |
| 275 | GUTS | Fractyl Health, Inc. | 274.09M | -2.91% | 4,343,691 | 3.00K |
| 276 | IKT | Inhibikase Therapeutics, Inc. | 272.88M | -0.75% | 859,669 | 1.00 |
| 277 | SLN | Silence Therapeutics plc | 270.65M | -3.37% | 278,461 | 25.83M |
| 278 | AVIR | Atea Pharmaceuticals, Inc. | 266.41M | - | 459,596 | - |
| 279 | ACHV | Achieve Life Sciences, Inc. | 265.64M | -3.85% | 726,647 | - |
| 280 | OABI | OmniAb, Inc. | 264.16M | -0.81% | 186,237 | 21.09M |
| 281 | IMMX | Immix Biopharma, Inc. | 260.84M | -2.94% | 896,578 | - |
| 282 | FENC | Fennec Pharmaceuticals Inc. | 252.05M | -1.60% | 53,026 | 38.79M |
| 283 | STTK | Shattuck Labs, Inc. | 251.85M | 2.31% | 575,837 | 1.00M |
| 284 | OBIO | Orchestra BioMed Holdings, Inc. | 251.27M | 4.95% | 146,197 | 2.82M |
| 285 | ALDX | Aldeyra Therapeutics, Inc. | 244.26M | -4.25% | 1,118,415 | - |
| 286 | MDWD | MediWound Ltd. | 240.66M | 1.57% | 72,238 | 20.93M |
| 287 | NAUT | Nautilus Biotechnology, Inc. | 236.19M | -1.06% | 93,185 | - |
| 288 | OVID | Ovid Therapeutics Inc. | 229.12M | 6.02% | 2,226,630 | 6.61M |
| 289 | HRTX | Heron Therapeutics, Inc. | 223.70M | -1.61% | 1,256,721 | 155.10M |
| 290 | VYGR | Voyager Therapeutics, Inc. | 223.51M | -1.47% | 313,861 | 31.32M |
| 291 | GALT | Galectin Therapeutics Inc. | 222.43M | -11.08% | 905,352 | - |
| 292 | PRQR | ProQR Therapeutics N.V. | 219.12M | 1.96% | 277,113 | 18.86M |
| 293 | CBIO | Crescent Biopharma, Inc. | 216.41M | -0.36% | 56,468 | - |
| 294 | ARMP | Armata Pharmaceuticals, Inc. | 213.71M | -7.56% | 21,139 | 5.05M |
| 295 | NVCT | Nuvectis Pharma, Inc. | 211.32M | -3.28% | 112,153 | - |
| 296 | PRLD | Prelude Therapeutics Incorporated | 210.94M | 4.92% | 210,405 | 10.50M |
| 297 | EDIT | Editas Medicine, Inc. | 208.90M | 7.54% | 2,388,519 | 46.38M |
| 298 | HUMA | Humacyte, Inc. | 208.44M | 1.89% | 4,442,596 | 1.57M |
| 299 | MIST | Milestone Pharmaceuticals Inc. | 208.24M | 1.49% | 2,846,451 | - |
| 300 | CRDF | Cardiff Oncology, Inc. | 200.06M | 4.58% | 1,358,099 | 501.00K |
| 301 | CCCC | C4 Therapeutics, Inc. | 196.74M | - | 853,271 | 30.11M |
| 302 | CABA | Cabaletta Bio, Inc. | 196.38M | -7.27% | 3,027,209 | - |
| 303 | ENLV | Enlivex Therapeutics Ltd. | 194.44M | 4.82% | 259,913 | - |
| 304 | TNXP | Tonix Pharmaceuticals Holding Corp. | 190.33M | 0.92% | 533,772 | 10.30M |
| 305 | ARCT | Arcturus Therapeutics Holdings Inc. | 187.81M | 3.77% | 473,496 | 97.60M |
| 306 | NERV | Minerva Neurosciences, Inc. | 186.95M | 4.10% | 138,571 | - |
| 307 | ALEC | Alector, Inc. | 184.47M | 5.62% | 1,414,237 | 69.05M |
| 308 | RNAC | Cartesian Therapeutics, Inc. | 183.33M | 2.03% | 140,766 | 1.09M |
| 309 | CLYM | Climb Bio, Inc. | 181.91M | 7.63% | 468,481 | - |
| 310 | SGMT | Sagimet Biosciences Inc. | 177.24M | -1.62% | 296,521 | - |
| 311 | RZLT | Rezolute, Inc. | 177.11M | -2.80% | 4,897,678 | - |
| 312 | TLSA | Tiziana Life Sciences Ltd | 175.86M | -3.27% | 179,206 | - |
| 313 | NTHI | NeOnc Technologies Holdings, Inc. | 173.91M | -2.40% | 26,022 | 59.99K |
| 314 | SABS | SAB Biotherapeutics, Inc. | 171.38M | -3.74% | 65,155 | 114.70K |
| 315 | SRZN | Surrozen, Inc. | 169.52M | 3.55% | 78,574 | 3.60M |
| 316 | RANI | Rani Therapeutics Holdings, Inc. | 167.70M | 1.47% | 1,145,681 | 1.20M |
| 317 | IPHA | Innate Pharma S.A. | 167.23M | -0.73% | 37,906 | 14.84M |
| 318 | CHRS | Coherus Oncology, Inc. | 164.38M | -5.56% | 1,104,052 | 277.73M |
| 319 | MOLN | Molecular Partners AG | 163.53M | 4.01% | 1,808 | 856.30K |
| 320 | CRBU | Caribou Biosciences, Inc. | 160.77M | 6.83% | 852,980 | 9.30M |
| 321 | CDXS | Codexis, Inc. | 155.36M | 5.52% | 590,668 | 52.93M |
| 322 | ACTU | Actuate Therapeutics, Inc. | 154.80M | 5.05% | 94,592 | - |
| 323 | QNCX | Quince Therapeutics, Inc. | 154.79M | -2.80% | 790,597 | - |
| 324 | KLRS | Kalaris Therapeutics, Inc. | 154.48M | 0.98% | 83,665 | - |
| 325 | CNTX | Context Therapeutics Inc. | 151.60M | 6.45% | 2,950,295 | - |
| 326 | SGMO | Sangamo Therapeutics, Inc. | 149.44M | 0.93% | 3,157,441 | 32.88M |
| 327 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 149.34M | 2.94% | 146,146 | - |
| 328 | BDTX | Black Diamond Therapeutics, Inc. | 148.13M | 1.17% | 623,255 | 70.00M |
| 329 | MRSN | Mersana Therapeutics, Inc. | 145.39M | 0.76% | - | 33.18M |
| 330 | CGEN | Compugen Ltd. | 144.98M | 1.97% | 260,751 | 6.90M |
| 331 | IRD | Opus Genetics, Inc. | 143.45M | -2.35% | 225,403 | 14.63M |
| 332 | PLX | Protalix BioTherapeutics, Inc. | 142.35M | -1.12% | 768,816 | 61.84M |
| 333 | SPRO | Spero Therapeutics, Inc. | 141.41M | 3.29% | 278,921 | 40.55M |
| 334 | ELTX | Elicio Therapeutics, Inc. | 141.02M | 2.67% | 47,116 | - |
| 335 | MCRB | Seres Therapeutics, Inc. | 140.67M | 2.37% | 40,387 | 351.00K |
| 336 | NKTX | Nkarta, Inc. | 137.09M | 1.58% | 584,719 | - |
| 337 | ACOG | Alpha Cognition Inc. | 134.15M | - | 11,961 | 7.43M |
| 338 | TTRX | Turn Therapeutics Inc. | 132.21M | -5.07% | 42,698 | - |
| 339 | FBIO | Fortress Biotech, Inc. | 130.67M | -1.41% | 885,514 | 62.30M |
| 340 | VRCA | Verrica Pharmaceuticals Inc. | 128.72M | -9.24% | 199,208 | 30.83M |
| 341 | SLGL | Sol-Gel Technologies Ltd. | 128.03M | 4.01% | 7,834 | 18.97M |
| 342 | GNLX | Genelux Corporation | 127.53M | -2.59% | 353,702 | 8.00K |
| 343 | CBUS | Cibus, Inc. | 127.02M | 15.84% | 548,796 | 3.79M |
| 344 | CNTB | Connect Biopharma Holdings Limited | 126.34M | -5.83% | 64,285 | 762.00K |
| 345 | KPTI | Karyopharm Therapeutics Inc. | 125.32M | -0.68% | 418,108 | 142.53M |
| 346 | ELDN | Eledon Pharmaceuticals, Inc. | 124.75M | 0.61% | 879,173 | - |
| 347 | CGTX | Cognition Therapeutics, Inc. | 124.47M | 0.71% | 1,069,856 | - |
| 348 | TNYA | Tenaya Therapeutics, Inc. | 124.03M | 2.27% | 2,666,938 | - |
| 349 | ORMP | Oramed Pharmaceuticals Inc. | 122.19M | 3.72% | 132,091 | 2.00M |
| 350 | UNCY | Unicycive Therapeutics, Inc. | 121.43M | 2.36% | 265,094 | - |
| 351 | WHWK | Whitehawk Therapeutics, Inc. | 118.76M | -0.40% | 58,480 | 14.38M |
| 352 | ABOS | Acumen Pharmaceuticals, Inc. | 118.72M | -1.01% | 165,786 | - |
| 353 | DWTX | Dogwood Therapeutics, Inc. | 118.02M | -5.92% | 20,343 | - |
| 354 | AGEN | Agenus Inc. | 118.01M | 7.76% | 907,220 | 106.83M |
| 355 | FATE | Fate Therapeutics, Inc. | 116.51M | - | 1,541,207 | 7.14M |
| 356 | ZNTL | Zentalis Pharmaceuticals, Inc. | 115.26M | 29.93% | 9,107,561 | 26.87M |
| 357 | RPTX | Repare Therapeutics Inc. | 111.00M | 0.19% | 1,426,609 | 11.87M |
| 358 | INO | Inovio Pharmaceuticals, Inc. | 109.93M | 0.63% | 4,537,533 | 182.34K |
| 359 | COYA | Coya Therapeutics, Inc. | 109.85M | -2.05% | 163,929 | 3.99M |
| 360 | HYFT | MindWalk Holdings Corp. | 108.32M | 2.65% | 450,876 | 19.02M |
| 361 | THAR | Tharimmune, Inc. | 108.29M | -3.13% | 555,743 | - |
| 362 | ARTV | Artiva Biotherapeutics, Inc. | 108.24M | 5.76% | 182,044 | 251.00K |
| 363 | MGNX | MacroGenics, Inc. | 107.54M | -1.16% | 826,930 | 127.63M |
| 364 | ATRA | Atara Biotherapeutics, Inc. | 105.05M | -13.58% | 226,625 | 151.93M |
| 365 | ANIX | Anixa Biosciences, Inc. | 104.68M | - | 175,307 | - |
| 366 | ONCY | Oncolytics Biotech Inc. | 103.82M | -0.02% | 294,718 | - |
| 367 | SEER | Seer, Inc. | 102.94M | -0.54% | 105,563 | 16.38M |
| 368 | SAVA | Cassava Sciences, Inc. | 102.41M | 0.95% | 551,455 | - |
| 369 | ANVS | Annovis Bio, Inc. | 102.04M | 1.32% | 443,837 | - |
| 370 | DTIL | Precision BioSciences, Inc. | 101.34M | 3.19% | 182,721 | 698.00K |
| 371 | GANX | Gain Therapeutics, Inc. | 98.08M | -14.14% | 3,198,539 | - |
| 372 | ETHZ | ETHZilla Corporation | 97.71M | -3.73% | 838,413 | 4.11M |
| 373 | STRO | Sutro Biopharma, Inc. | 97.38M | 5.15% | 67,711 | 105.65M |
| 374 | ACRV | Acrivon Therapeutics, Inc. | 94.98M | 31.44% | 3,201,092 | - |
| 375 | CSBR | Champions Oncology, Inc. | 94.29M | 1.19% | 3,556 | 58.42M |
| 376 | VANI | Vivani Medical, Inc. | 91.92M | - | 85,340 | - |
| 377 | VXRT | Vaxart, Inc. | 90.35M | -1.23% | - | 148.20M |
| 378 | BMEA | Biomea Fusion, Inc. | 89.09M | -1.56% | 597,541 | - |
| 379 | SPRB | Spruce Biosciences, Inc. | 86.68M | -1.39% | 48,543 | 697.00K |
| 380 | ADAG | Adagene Inc. | 85.78M | 2.25% | 31,995 | 103.20K |
| 381 | ATOS | Atossa Therapeutics, Inc. | 85.30M | 7.00% | 2,351,871 | - |
| 382 | EXOZ | eXoZymes, Inc. | 84.85M | -5.08% | 2,706 | -700.00 |
| 383 | PTHS | Pelthos Therapeutics Inc. | 84.70M | 2.43% | 6,602 | 7.41M |
| 384 | CALC | CalciMedica, Inc. | 82.57M | -4.66% | 178,750 | - |
| 385 | ACET | Adicet Bio, Inc. | 81.36M | -1.23% | 163,597 | - |
| 386 | COEP | Coeptis Therapeutics Holdings, Inc. | 81.01M | 2.57% | 32,399 | 501.00K |
| 387 | PYXS | Pyxis Oncology, Inc. | 80.94M | 7.44% | 1,336,037 | 2.82M |
| 388 | OKYO | OKYO Pharma Limited | 79.73M | -11.67% | 159,957 | - |
| 389 | IFRX | InflaRx N.V. | 79.26M | 2.63% | 630,295 | 73.73K |
| 390 | PLRX | Pliant Therapeutics, Inc. | 78.66M | -0.39% | 2,034,853 | - |
| 391 | IPSC | Century Therapeutics, Inc. | 78.58M | -9.49% | 495,896 | 113.34M |
| 392 | EQ | Equillium, Inc. | 78.55M | -17.83% | 879,078 | 4.39M |
| 393 | KRRO | Korro Bio, Inc. | 77.79M | 3.25% | 174,760 | 7.37M |
| 394 | XBIT | XBiotech Inc. | 77.13M | 3.69% | 47,324 | - |
| 395 | PSTV | Plus Therapeutics, Inc. | 77.10M | 0.02% | 3,117,235 | 5.26M |
| 396 | PYPD | PolyPid Ltd. | 76.02M | 2.24% | 85,991 | - |
| 397 | IMUX | Immunic, Inc. | 75.00M | -2.15% | 1,467,273 | - |
| 398 | ENTX | Entera Bio Ltd. | 72.00M | -11.30% | 1,477,419 | 124.00K |
| 399 | KZIA | Kazia Therapeutics Limited | 71.48M | 14.69% | 352,442 | 1.20M |
| 400 | ATYR | aTyr Pharma, Inc. | 70.97M | -2.91% | 2,233,707 | 190.00K |
| 401 | NRXP | NRx Pharmaceuticals, Inc. | 70.76M | -0.83% | 594,281 | 242.00K |
| 402 | IMA | ImageneBio, Inc. | 70.51M | 3.28% | 56,758 | 800.00K |
| 403 | CRVO | CervoMed Inc. | 69.81M | -3.39% | 28,266 | 6.16M |
| 404 | TVGN | Tevogen Bio Holdings Inc. | 69.36M | -2.76% | 464,857 | - |
| 405 | MNOV | MediciNova, Inc. | 67.82M | - | 22,675 | 257.92K |
| 406 | ATHE | Alterity Therapeutics Limited | 65.90M | -1.23% | 1,923 | 3.57M |
| 407 | MGX | Metagenomi, Inc. | 65.33M | 1.75% | 269,752 | 30.91M |
| 408 | PMVP | PMV Pharmaceuticals, Inc. | 64.92M | - | 150,860 | - |
| 409 | TCRX | TScan Therapeutics, Inc. | 64.69M | 9.62% | 815,326 | 8.42M |
| 410 | BYSI | BeyondSpring Inc. | 61.68M | -0.66% | 62,230 | 1.88M |
| 411 | MREO | Mereo BioPharma Group plc | 60.31M | -21.14% | 39,492,865 | 500.00K |
| 412 | PASG | Passage Bio, Inc. | 58.68M | 14.59% | 267,785 | - |
| 413 | ALXO | ALX Oncology Holdings Inc. | 58.56M | -3.57% | 220,183 | - |
| 414 | MAIA | MAIA Biotechnology, Inc. | 58.55M | 1.32% | 299,987 | - |
| 415 | ICCC | ImmuCell Corporation | 57.44M | 4.96% | 21,785 | 27.77M |
| 416 | LITS | Lite Strategy, Inc. | 56.65M | 0.65% | 471,263 | - |
| 417 | INKT | MiNK Therapeutics, Inc. | 56.52M | -0.17% | 5,745 | - |
| 418 | GRCE | Grace Therapeutics, Inc. | 55.78M | -0.69% | 180,048 | - |
| 419 | IBO | Impact BioMedical Inc. | 55.45M | 1.77% | 85,693 | 25.00K |
| 420 | RADX | Radiopharm Theranostics Limited | 54.74M | -5.88% | 91,820 | 8.20M |
| 421 | ALGS | Aligos Therapeutics, Inc. | 54.46M | 5.23% | 22,318 | 2.65M |
| 422 | ANL | Adlai Nortye Ltd. | 53.87M | 4.29% | 58,650 | -1.35M |
| 423 | ABVC | ABVC BioPharma, Inc. | 53.50M | -3.40% | 21,990 | 797.92K |
| 424 | NTRB | Nutriband Inc. | 53.49M | -1.79% | 16,560 | 2.28M |
| 425 | JSPR | Jasper Therapeutics, Inc. | 53.17M | 3.83% | 311,244 | - |
| 426 | CVM | CEL-SCI Corporation | 52.89M | 4.83% | 56,363 | - |
| 427 | OSTX | OS Therapies Incorporated | 52.12M | 2.78% | 188,445 | - |
| 428 | ESLA | Estrella Immunopharma, Inc. | 51.74M | 3.01% | 162,922 | - |
| 429 | TELO | Telomir Pharmaceuticals, Inc. | 49.85M | -2.68% | 128,185 | - |
| 430 | PDSB | PDS Biotechnology Corporation | 49.67M | 6.36% | 429,543 | - |
| 431 | ANEB | Anebulo Pharmaceuticals, Inc. | 47.66M | 2.65% | 17,252 | - |
| 432 | NRXS | NeurAxis, Inc. | 47.51M | 1.13% | 97,300 | 3.36M |
| 433 | PTN | Palatin Technologies, Inc. | 47.18M | -11.51% | 71,910 | 8.85M |
| 434 | IBIO | iBio, Inc. | 46.32M | 9.57% | 18,324,903 | 500.00K |
| 435 | IOBT | IO Biotech, Inc. | 46.00M | 4.82% | 667,721 | - |
| 436 | NXTC | NextCure, Inc. | 45.96M | -3.60% | 57,089 | - |
| 437 | KZR | Kezar Life Sciences, Inc. | 45.77M | -0.32% | 3,177 | - |
| 438 | TIL | Instil Bio, Inc. | 45.17M | -45.81% | 2,516,501 | - |
| 439 | ATNM | Actinium Pharmaceuticals, Inc. | 44.61M | -1.38% | 125,641 | 90.00K |
| 440 | HURA | TuHURA Biosciences, Inc. | 44.07M | -1.28% | 209,018 | - |
| 441 | APLM | Apollomics, Inc. | 43.46M | 6.64% | 19,771 | 6.93M |
| 442 | EVAX | Evaxion A/S | 42.12M | 5.21% | 53,032 | 7.65M |
| 443 | LPCN | Lipocine Inc. | 41.72M | 2.95% | 96,488 | 4.32M |
| 444 | INMB | INmune Bio, Inc. | 41.47M | 4.70% | 321,757 | 50.00K |
| 445 | QTTB | Q32 Bio Inc. | 41.47M | - | 106,033 | - |
| 446 | LTRN | Lantern Pharma Inc. | 39.03M | 7.38% | 62,251 | - |
| 447 | BTAI | BioXcel Therapeutics, Inc. | 38.05M | -2.79% | 441,617 | 752.00K |
| 448 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 37.75M | -2.56% | 5,401,379 | - |
| 449 | OKUR | OnKure Therapeutics, Inc. | 37.66M | -3.14% | 29,417 | - |
| 450 | XCUR | Exicure, Inc. | 37.54M | 4.62% | 59,361 | 500.00K |
| 451 | VERU | Veru Inc. | 37.40M | 1.75% | 106,175 | 16.89M |
| 452 | RNXT | RenovoRx, Inc. | 37.38M | 7.37% | 494,888 | 928.00K |
| 453 | FGEN | FibroGen, Inc. | 37.08M | 2.63% | 22,752 | 8.30M |
| 454 | TVRD | Tvardi Therapeutics, Inc. | 36.87M | -2.48% | 80,509 | - |
| 455 | XLO | Xilio Therapeutics, Inc. | 36.49M | 2.76% | 605,211 | 31.80M |
| 456 | JUNS | Jupiter Neurosciences, Inc. | 36.32M | 1.44% | 59,938 | - |
| 457 | GBIO | Generation Bio Co. | 36.25M | -0.37% | 55,027 | 15.27M |
| 458 | CELU | Celularity Inc. | 35.60M | -0.79% | 29,442 | 40.58M |
| 459 | GLTO | Galecto, Inc. | 34.84M | 2.73% | 23,301 | - |
| 460 | OTLK | Outlook Therapeutics, Inc. | 33.95M | -2.41% | 14,776,500 | 1.41M |
| 461 | DYAI | Dyadic International, Inc. | 33.65M | 2.19% | 47,394 | 3.34M |
| 462 | GNTA | Genenta Science S.p.A. | 33.51M | -0.69% | 40,210 | - |
| 463 | CUE | Cue Biopharma, Inc. | 33.49M | -4.05% | 971,493 | 7.10M |
| 464 | SKYE | Skye Bioscience, Inc. | 32.38M | 17.73% | 986,861 | - |
| 465 | RNTX | Rein Therapeutics Inc. | 32.07M | -3.17% | 72,445 | - |
| 466 | CING | Cingulate Inc. | 31.62M | -1.47% | 270,594 | - |
| 467 | HYPD | Hyperion DeFi, Inc. | 31.46M | -2.78% | 292,813 | 345.32K |
| 468 | HOWL | Werewolf Therapeutics, Inc. | 31.17M | -0.34% | 355,264 | 1.14M |
| 469 | LIXT | Lixte Biotechnology Holdings, Inc. | 31.02M | -5.82% | 95,398 | - |
| 470 | MRKR | Marker Therapeutics, Inc. | 31.01M | 3.91% | 922,126 | 4.69M |
| 471 | ANTX | AN2 Therapeutics, Inc. | 29.32M | - | 134,106 | - |
| 472 | BRNS | Barinthus Biotherapeutics plc | 28.99M | -2.34% | 55,125 | 14.97M |
| 473 | SNTI | Senti Biosciences, Inc. | 28.92M | -2.65% | 232,926 | - |
| 474 | RLYB | Rallybio Corporation | 28.68M | -0.01% | 99,075 | 674.00K |
| 475 | VTGN | Vistagen Therapeutics, Inc. | 28.50M | 0.22% | 1,400,861 | 721.00K |
| 476 | DARE | Daré Bioscience, Inc. | 28.01M | -1.51% | 47,955 | -57.13K |
| 477 | QNTM | Quantum BioPharma Ltd. | 27.75M | -3.04% | 49,825 | - |
| 478 | BOLD | Boundless Bio, Inc. | 27.53M | 4.24% | 101,043 | - |
| 479 | ATHA | Athira Pharma, Inc. | 27.41M | 5.62% | 167,617 | - |
| 480 | PLUR | Pluri Inc. | 26.94M | -1.35% | 4,471 | 1.33M |
| 481 | IGC | IGC Pharma, Inc. | 26.84M | -1.26% | 436,919 | 1.11M |
| 482 | PLRZ | Polyrizon Ltd. | 26.21M | 4.98% | 98,280 | - |
| 483 | NRSN | NeuroSense Therapeutics Ltd. | 25.70M | -1.69% | 243,469 | - |
| 484 | BCAB | BioAtla, Inc. | 25.41M | 1.25% | 1,794,286 | 11.00M |
| 485 | NNVC | NanoViricides, Inc. | 24.99M | -1.54% | 311,393 | - |
| 486 | KTTA | Pasithea Therapeutics Corp. | 24.19M | -2.70% | 296,808 | - |
| 487 | INTS | Intensity Therapeutics, Inc. | 23.73M | -0.25% | 935,942 | - |
| 488 | KLTO | Klotho Neurosciences, Inc. | 23.68M | 1.56% | 309,665 | - |
| 489 | SER | Serina Therapeutics, Inc. | 22.18M | - | 34,927 | 116.00K |
| 490 | LNAI | Lunai Bioworks Inc. | 21.55M | -2.22% | 136,755 | - |
| 491 | NEUP | Neuphoria Therapeutics Inc. | 21.40M | 3.65% | 63,532 | 15.65M |
| 492 | CTXR | Citius Pharmaceuticals, Inc. | 20.35M | 4.27% | 378,005 | - |
| 493 | ALLR | Allarity Therapeutics, Inc. | 19.27M | -0.89% | 66,988 | - |
| 494 | CLGN | CollPlant Biotechnologies Ltd. | 18.53M | 0.69% | 8,460 | 2.48M |
| 495 | ITRM | Iterum Therapeutics plc | 18.49M | -1.07% | 649,747 | 390.00K |
| 496 | VYNE | VYNE Therapeutics Inc. | 18.43M | -1.98% | 1,082,586 | 524.00K |
| 497 | LIMN | Liminatus Pharma, Inc. | 18.00M | -2.61% | 37,936 | - |
| 498 | MTVA | MetaVia Inc. | 17.83M | -7.22% | 48,814 | - |
| 499 | CASI | CASI Pharmaceuticals, Inc. | 17.47M | 0.15% | 6,298 | 26.85M |
| 500 | LEXX | Lexaria Bioscience Corp. | 17.44M | -1.24% | 374,004 | 705.92K |
| 501 | FBLG | FibroBiologics, Inc. | 17.30M | 6.78% | 2,006,259 | - |
| 502 | LSTA | Lisata Therapeutics, Inc. | 17.29M | 1.55% | 56,197 | 1.07M |
| 503 | PMN | ProMIS Neurosciences, Inc. | 16.54M | 3.81% | 25,536 | - |
| 504 | KAPA | Kairos Pharma, Ltd. | 16.47M | 1.68% | 144,058 | - |
| 505 | CVKD | Cadrenal Therapeutics, Inc. | 16.20M | -5.33% | 56,023 | - |
| 506 | HOTH | Hoth Therapeutics, Inc. | 16.13M | -1.89% | 92,289 | - |
| 507 | GDTC | CytoMed Therapeutics Limited | 16.04M | 2.21% | 10,152 | 573.19K |
| 508 | GRDX | GridAI Technologies Corp. | 15.46M | -5.15% | 278,081 | - |
| 509 | OSRH | OSR Holdings, Inc. | 15.40M | 1.88% | 143,853 | -90.52K |
| 510 | NCNA | NuCana plc | 15.40M | - | 80,511 | - |
| 511 | KALA | KALA BIO, Inc. | 15.31M | 6.90% | 8,551,724 | - |
| 512 | APLT | Applied Therapeutics, Inc. | 15.30M | 6.00% | 3,845,005 | 1.00M |
| 513 | COCP | Cocrystal Pharma, Inc. | 15.09M | 0.46% | 50,176 | - |
| 514 | BCTX | BriaCell Therapeutics Corp. | 14.75M | -6.27% | 125,163 | - |
| 515 | AEON | AEON Biopharma, Inc. | 14.68M | 9.73% | 169,706 | - |
| 516 | SNGX | Soligenix, Inc. | 14.22M | -1.40% | 181,087 | 2.34K |
| 517 | SYBX | Synlogic, Inc. | 13.92M | - | 6,926 | 8.00K |
| 518 | TPST | Tempest Therapeutics, Inc. | 13.92M | 0.18% | 71,578 | - |
| 519 | SNSE | Sensei Biotherapeutics, Inc. | 13.72M | 11.82% | 58,975 | - |
| 520 | CLRB | Cellectar Biosciences, Inc. | 13.65M | -3.88% | 97,701 | - |
| 521 | BCDA | BioCardia, Inc. | 13.48M | - | 42,895 | 3.00K |
| 522 | AKTX | Akari Therapeutics, Plc | 13.28M | -1.43% | 430,222 | - |
| 523 | BLRX | BioLineRx Ltd. | 13.18M | 1.74% | 6,323 | 12.74M |
| 524 | ABP | Abpro Holdings, Inc. | 13.17M | 19.75% | 35,310 | 183.00K |
| 525 | CRIS | Curis, Inc. | 12.93M | 1.55% | 75,023 | 11.65M |
| 526 | MBRX | Moleculin Biotech, Inc. | 12.69M | 5.64% | 192,954 | - |
| 527 | LGVN | Longeveron Inc. | 12.51M | 2.64% | 251,068 | 1.44M |
| 528 | EDSA | Edesa Biotech, Inc. | 12.42M | 0.66% | 27,162 | - |
| 529 | PHIO | Phio Pharmaceuticals Corp. | 12.38M | -1.71% | 451,857 | - |
| 530 | IMNN | Imunon, Inc. | 12.13M | - | 65,875 | - |
| 531 | QNRX | Quoin Pharmaceuticals, Ltd. | 11.75M | -0.36% | 11,131 | - |
| 532 | INAB | IN8bio, Inc. | 11.45M | - | 112,455 | - |
| 533 | BOLT | Bolt Biotherapeutics, Inc. | 11.29M | 3.89% | 17,575 | 5.20M |
| 534 | ASBP | Aspire Biopharma Holdings, Inc. | 11.29M | -12.65% | 21,413,167 | 1.94K |
| 535 | CMMB | Chemomab Therapeutics Ltd. | 11.14M | -3.21% | 52,699 | - |
| 536 | NCEL | NewcelX Ltd. | 10.62M | 4.48% | 89,933 | - |
| 537 | BIVI | BioVie Inc. | 10.48M | 6.11% | 205,398 | - |
| 538 | BRTX | BioRestorative Therapies, Inc. | 10.39M | -2.15% | 13,445 | 383.40K |
| 539 | TRAW | Traws Pharma, Inc. | 10.31M | - | 57,382 | 2.85M |
| 540 | ERNA | Ernexa Therapeutics Inc. | 9.97M | 4.96% | 2,833,399 | 1,000.00 |
| 541 | EVGN | Evogene Ltd. | 9.85M | 2.68% | 34,445 | 8.02M |
| 542 | GOVX | GeoVax Labs, Inc. | 9.34M | 14.47% | 3,431,112 | 3.35M |
| 543 | ICU | SeaStar Medical Holding Corporation | 9.30M | - | 112,356 | 881.00K |
| 544 | APM | Aptorum Group Limited | 8.55M | 2.94% | 17,822 | - |
| 545 | GTBP | GT Biopharma, Inc. | 8.45M | -0.75% | 1,123,316 | - |
| 546 | CLDI | Calidi Biotherapeutics, Inc. | 8.42M | -1.71% | 23,553 | - |
| 547 | PULM | Pulmatrix, Inc. | 8.40M | 1.32% | 22,508 | 3.00K |
| 548 | TOVX | Theriva Biologics, Inc. | 8.19M | 0.66% | 2,891,508 | - |
| 549 | ALZN | Alzamend Neuro, Inc. | 8.10M | 3.90% | 43,975 | - |
| 550 | MBIO | Mustang Bio, Inc. | 7.96M | -1.80% | 40,083 | - |
| 551 | PMCB | PharmaCyte Biotech, Inc. | 7.82M | 1.31% | 241,982 | - |
| 552 | ADXN | Addex Therapeutics Ltd | 7.79M | -4.20% | 18 | 198.82K |
| 553 | CELZ | Creative Medical Technology Holdings, Inc. | 7.79M | 9.31% | 639,647 | 6.00K |
| 554 | KPRX | Kiora Pharmaceuticals, Inc. | 7.78M | 0.95% | 14,566 | 20.00K |
| 555 | IMRN | Immuron Limited | 7.65M | 1.22% | 11,735 | 4.78M |
| 556 | PCSA | Processa Pharmaceuticals, Inc. | 7.61M | 4.02% | 93,743 | - |
| 557 | APVO | Aptevo Therapeutics Inc. | 7.44M | -4.45% | 66,950 | - |
| 558 | CYCN | Cyclerion Therapeutics, Inc. | 7.42M | 41.30% | 71,887,253 | 2.86M |
| 559 | TCRT | Alaunos Therapeutics, Inc. | 7.16M | -1.83% | 12,194 | 6.00K |
| 560 | PPCB | Propanc Biopharma, Inc. | 6.77M | -6.53% | 57,145 | - |
| 561 | RNAZ | TransCode Therapeutics, Inc. | 6.75M | 0.68% | 2,265,235 | - |
| 562 | BGMS | Bio Green Med Solution, Inc. | 6.66M | -0.73% | 23,992 | 81.00K |
| 563 | SLXN | Silexion Therapeutics Corp | 6.60M | -4.09% | 32,683 | - |
| 564 | XTLB | XTL Biopharmaceuticals Ltd. | 6.59M | 8.52% | 30,793 | 968.00K |
| 565 | ADIL | Adial Pharmaceuticals, Inc. | 6.57M | -3.37% | 403,214 | - |
| 566 | PPBT | Purple Biotech Ltd | 6.47M | 0.92% | 54,655 | - |
| 567 | LYRA | Lyra Therapeutics, Inc. | 6.14M | 2.37% | 15,221 | 600.00K |
| 568 | ACXP | Acurx Pharmaceuticals, Inc. | 6.09M | 2.10% | 40,352 | - |
| 569 | CANF | Can-Fite BioPharma Ltd. | 6.07M | -7.23% | 218,248 | 560.00K |
| 570 | APRE | Aprea Therapeutics, Inc. | 5.76M | 3.84% | 131,474 | 488.24K |
| 571 | REVB | Revelation Biosciences, Inc. | 5.45M | 9.68% | 213,750 | - |
| 572 | CDIO | Cardio Diagnostics Holdings, Inc. | 5.40M | -0.84% | 18,593 | 15.78K |
| 573 | VIVS | VivoSim Labs, Inc. | 5.32M | 4.62% | 45,179 | 140.00K |
| 574 | JAGX | Jaguar Health, Inc. | 5.13M | 9.71% | 192,977 | 11.79M |
| 575 | SILO | Silo Pharma, Inc. | 5.06M | 7.22% | 104,367 | 72.10K |
| 576 | XBIO | Xenetic Biosciences, Inc. | 5.04M | 0.23% | 22,227 | 2.86M |
| 577 | SPRC | SciSparc Ltd. | 4.82M | 1.38% | 87,254 | 1.31M |
| 578 | INDP | Indaptus Therapeutics, Inc. | 4.54M | 2.78% | 81,015 | - |
| 579 | GLMD | Galmed Pharmaceuticals Ltd. | 4.51M | -2.40% | 30,275 | - |
| 580 | GNPX | Genprex, Inc. | 4.38M | 5.00% | 1,842,555 | - |
| 581 | SLRX | Salarius Pharmaceuticals, Inc. | 4.15M | 21.50% | 704,449 | - |
| 582 | ENVB | Enveric Biosciences, Inc. | 4.13M | 0.25% | 30,473 | - |
| 583 | XRTX | XORTX Therapeutics Inc. | 4.06M | -0.39% | 31,954 | - |
| 584 | CMND | Clearmind Medicine Inc. | 4.03M | 8.03% | 140,404 | - |
| 585 | MTNB | Matinas BioPharma Holdings, Inc. | 3.83M | -6.84% | 34,074 | - |
| 586 | ENSC | Ensysce Biosciences, Inc. | 3.67M | -2.88% | 97,491 | 4.49M |
| 587 | OGEN | Oragenics, Inc. | 3.63M | -0.45% | 52,784 | - |
| 588 | PHGE | BiomX Inc. | 3.39M | -1.77% | 48,969 | - |
| 589 | CNSP | CNS Pharmaceuticals, Inc. | 3.29M | 0.35% | 8,284 | - |
| 590 | HCWB | HCW Biologics Inc. | 3.24M | 8.11% | 75,075 | 422.03K |
| 591 | AZTR | Azitra, Inc. | 3.06M | 0.28% | 220,413 | 7.50K |
| 592 | GRI | GRI Bio, Inc. | 3.06M | -2.01% | 1,004,469 | - |
| 593 | VRAX | Virax Biolabs Group Limited | 2.76M | 9.80% | 477,759 | 2.99K |
| 594 | ONCO | Onconetix, Inc. | 2.72M | 5.42% | 22,062 | 1.22M |
| 595 | ARTL | Artelo Biosciences, Inc. | 2.64M | 0.77% | 35,682 | - |
| 596 | SCNI | Scinai Immunotherapeutics Ltd. | 2.63M | 10.08% | 4,761 | 1.15M |
| 597 | CDT | CDT Equity Inc. | 2.46M | 7.86% | 65,420 | - |
| 598 | DRMA | Dermata Therapeutics, Inc. | 2.32M | 2.73% | 105,571 | - |
| 599 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.18M | 4.70% | 301,922 | 1.36M |
| 600 | BDRX | Biodexa Pharmaceuticals Plc | 2.06M | -2.39% | 57,975 | 104.90K |
| 601 | ADTX | Aditxt, Inc. | 1.57M | -7.26% | 247,239 | 5.95K |
| 602 | PBM | Psyence Biomedical Ltd. | 1.38M | 1.31% | 167,125 | - |
| 603 | ELAB | PMGC Holdings Inc. | 1.05M | -12.73% | 4,721,200 | 285.95K |
| 604 | MLEC | Moolec Science SA | 1.02M | - | 89,171 | 7.83M |